Management of a Tonsil Cancer Patient: From Work-up through Late Radiation Toxicity - 2021 Annual Meeting
This course guides the audience through a very practical approach to work up and management of an HPV+ tonsil cancer patient (T1N1), from initial examination and work-up through late complications. A community radiation oncologist, a medical oncologist, and a speech therapist will discuss current work up, staging, treatment including contouring and DVH evaluation. The speakers discuss recommended concurrent chemo regimens summarizing the latest literature on weekly vs q3week cis, mentioning recent RTOG 1016 and DeESCALaTE results, data on 30mg/m2 vs 40mg/m2 weekly cis, common chemotherapy side effects and management of those side effects, amount/timing of recommended IV fluid supplementation, and laboratory monitoring (timing of WBC nadir).
Additionally, reasons speakers cover when to give non-cisplatin regimens and what the recommended alternatives are. A speech therapist presents on preferred timing of referrals, guidance provided during radiation therapy, when/how often/patient symptoms to indicate swallow study, type of study to order, how/when to wean them off feeding tube, and late dysphagia assessments.
This activity is available from February 7, 2022, through 11:59 p.m. Eastern time on February 6, 2025.
This activity was originally recorded at ASTRO’s 2021 Annual Meeting, October 24-27th.
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents, medical oncologists and radiation physicists.
Upon completion of this activity, participants should be able to:
- Analyze current clinical data and understand evolving approaches to the management of head and neck cancer.
- Determine appropriate referrals, timing, and expectations from speech therapy.
- Thomas P. Boike, MD, MMM, Genesis Care / Michigan Healthcare Professionals and receives compensation from Boston Scientific and Blue Earth.
- Arshin Sheybani, MD, John Stoddard Cancer Center and has no financial relationships with a commercial interest.
- Carryn M. Anderson, MD, University of Iowa Hospitals & Clinics and receives compensation from Elekta. Dr. Anderson is an Iowa Association of Nurse Anesthetists Officer/Board Member.
- Katharine Price, MD, Division of Medical Oncology, Mayo Clinic and has no financial relationships with a commercial interest.
- Teresa Lyden, MA, Department of Otolaryngology, University of Michigan and has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.